Tissue transglutaminase levels above 100 U/mL and celiac disease: A prospective study

A Mubarak, VM Wolters, FHJ Gmelig-Meyling, Fiebo Kate, RHJ Houwen

Research output: Contribution to journalArticleAcademicpeer-review

49 Citations (Scopus)


AIM: To investigate whether a tissue-transglutaminase antibody (tTGA) level >= 100 U/mL is sufficient for the diagnosis of celiac disease (CD). METHODS: Children suspected of having CD were prospectively included in our study between March 2009 and September 2011. All patients with immune globulin A deficiency and all patients on a gluten-free diet were excluded from the study. Anti-endomysium antibodies (EMA) were detected by means of immunofluorescence using sections of distal monkey esophagus (EUROIM-MUN, Luebeck, Germany). Serum anti-tTGA were measured by means of enzyme-linked immunosorbent assay using human recombinant tissue tran RESULTS: A total of 183 children were included in the study. A total of 70 (38.3%) were male, while 113 (61.7%) were female. The age range was between 1.0 and 17.6 years, and the mean age was.6.2 years. One hundred twenty (65.6%) patients had a small intestinal biopsy diagnostic for the disease; 3 patients had a Marsh II lesion, and 117 patients had a Marsh M lesion. Of the patients without CD, only 4 patients had a Marsh I lesion. Of the 183 patients, 136 patients were positive for EMA, of whom CONCLUSION: This study confirms based on prospective data that a small intestinal biopsy is not necessary for the diagnosis of CD in symptomatic patients with tTGA >= 100 U/mL. (C) 2012 Baishideng. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)4399-4403
Number of pages5
JournalWorld Journal of Gastroenterology
Issue number32
Publication statusPublished - 2012

Cite this